Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Necrotizing enterocolitis is associated with acute brain responses in preterm pigs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. CaMKII and MEK1/2 inhibition time-dependently modify inflammatory signaling in rat cerebral arteries during organ culture

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis plan

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Fatal pneumococcus meningitis in a child with complement factor ficolin-3 deficiency

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • R Zangari
  • E R Zanier
  • G Torgano
  • A Bersano
  • S Beretta
  • E Beghi
  • B Casolla
  • N Checcarelli
  • S Lanfranconi
  • A Maino
  • C Mandelli
  • G Micieli
  • F Orzi
  • E Picetti
  • M Silvestrini
  • N Stocchetti
  • B Zecca
  • P Garred
  • M G De Simoni
  • LEPAS group
Vis graf over relationer

BACKGROUND: Several lines of evidence support the involvement of the lectin pathway of complement (LP) in the pathogenesis of acute ischemic stroke. The aim of this multicenter observational study was to assess the prognostic value of different circulating LP initiators in acute stroke.

METHODS: Plasma levels of the LP initiators ficolin-1, -2, and -3 and mannose-binding lectin (MBL) were measured in 80 stroke patients at 6 h only and in 85 patients at 48 h and later. Sixty-one age- and sex-matched healthy individuals served as controls. Stroke severity was measured on admission using the National Institutes of Health Stroke Scale (NIHSS). The outcome was measured at 90 days by the modified Rankin Scale (mRS).

RESULTS: Ficolin-1 was decreased in patients compared with controls measured at 6 h (median 0.13 vs 0.33 μg/ml, respectively, p < 0.0001). At 48 h, ficolin-1 was significantly higher (0.45 μg/ml, p < 0.0001) compared to the 6 h samples and to controls. Likewise, ficolin-2 was decreased at 6 h (2.70 vs 4.40 μg/ml, p < 0.0001) but not at 48 h. Ficolin-3 was decreased both at 6 and 48 h (17.3 and 18.23 vs 21.5 μg/ml, p < 0.001 and <0.05, respectively). For MBL no difference was detected between patients and controls or within patients at the different time points. In multivariate analysis, early ficolin-1 was independently associated with unfavorable mRS outcome (adjusted odds ratio (OR): 2.21, confidence interval (CI) 95 % 1.11-4.39, p = 0.023). Early ficolin-1 improved the discriminating ability of an outcome model including NIHSS and age (area under the curve (AUC) 0.95, CI 95 % 0.90-0.99, p = 0.0001).

CONCLUSIONS: The ficolins are consumed within 6 h after stroke implicating activation of the LP. Early ficolin-1 is selectively related to 3-month unfavorable outcome.

TidsskriftJournal of Neuroinflammation
Sider (fra-til)16
StatusUdgivet - 2016

ID: 48989760